Literature DB >> 24637692

Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf cooperation council: dominance of OXA-48 and NDM producers.

Hosam M Zowawi1, Anna L Sartor2, Hanan H Balkhy3, Timothy R Walsh4, Sameera M Al Johani5, Reem Y AlJindan6, Mubarak Alfaresi7, Emad Ibrahim8, Amina Al-Jardani9, Seif Al-Abri10, Jameela Al Salman11, Ali A Dashti12, Abdullah H Kutbi13, Sanmarié Schlebusch14, Hanna E Sidjabat2, David L Paterson2.   

Abstract

The molecular epidemiology and mechanisms of resistance of carbapenem-resistant Enterobacteriaceae (CRE) were determined in hospitals in the countries of the Gulf Cooperation Council (GCC), namely, Saudi Arabia, United Arab Emirates, Oman, Qatar, Bahrain, and Kuwait. Isolates were subjected to PCR-based detection of antibiotic-resistant genes and repetitive sequence-based PCR (rep-PCR) assessments of clonality. Sixty-two isolates which screened positive for potential carbapenemase production were assessed, and 45 were found to produce carbapenemase. The most common carbapenemases were of the OXA-48 (35 isolates) and NDM (16 isolates) types; 6 isolates were found to coproduce the OXA-48 and NDM types. No KPC-type, VIM-type, or IMP-type producers were detected. Multiple clones were detected with seven clusters of clonally related Klebsiella pneumoniae. Awareness of CRE in GCC countries has important implications for controlling the spread of CRE in the Middle East and in hospitals accommodating patients transferred from the region.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24637692      PMCID: PMC4068443          DOI: 10.1128/AAC.02050-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  High prevalence of CTX-M-15-producing Klebsiella pneumoniae among inpatients and outpatients with urinary tract infection in Southern India.

Authors:  Yohei Doi; Jennifer M Adams-Haduch; Andrea Endimiani; Hanna E Sidjabat; Subhaschandra M Gaddad; David L Paterson
Journal:  J Antimicrob Chemother       Date:  2008-03-20       Impact factor: 5.790

2.  First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world.

Authors:  Amy J Mathers; Kevin C Hazen; Joanne Carroll; Anthony J Yeh; Heather L Cox; Robert A Bonomo; Costi D Sifri
Journal:  J Clin Microbiol       Date:  2012-11-21       Impact factor: 5.948

3.  Epidemiology of Acinetobacter spp.-associated healthcare infections and colonization among children at a tertiary-care hospital in Saudi Arabia: a 6-year retrospective cohort study.

Authors:  H H Balkhy; M S Bawazeer; R F Kattan; H M Tamim; S M Al Johani; F A Aldughashem; H A Al Alem; A Adlan; L A Herwaldt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-05       Impact factor: 3.267

4.  Identification of plasmids by PCR-based replicon typing.

Authors:  Alessandra Carattoli; Alessia Bertini; Laura Villa; Vincenzo Falbo; Katie L Hopkins; E John Threlfall
Journal:  J Microbiol Methods       Date:  2005-06-02       Impact factor: 2.363

Review 5.  OXA-48-like carbapenemases: the phantom menace.

Authors:  Laurent Poirel; Anaïs Potron; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2012-04-11       Impact factor: 5.790

6.  Nosocomial transmission of New Delhi metallo-β-lactamase-1-producing Klebsiella pneumoniae in Toronto, Canada.

Authors:  Christopher F Lowe; Julianne V Kus; Natasha Salt; Sandra Callery; Lisa Louie; Mohammed A Khan; Mary Vearncombe; Andrew E Simor
Journal:  Infect Control Hosp Epidemiol       Date:  2012-11-20       Impact factor: 3.254

7.  Evolution of tigecycline resistance in Klebsiella pneumoniae in a single patient.

Authors:  Nada S Al-Qadheeb; Sahar Althawadi; Abdulaziz Alkhalaf; Suleiman Hosaini; Abdulrahman A Alrajhi
Journal:  Ann Saudi Med       Date:  2010 Sep-Oct       Impact factor: 1.526

8.  High prevalence of VIM-4 and NDM-1 metallo-β-lactamase among carbapenem-resistant Enterobacteriaceae.

Authors:  Wafaa Jamal; Vincent O Rotimi; M John Albert; Fatima Khodakhast; Patrice Nordmann; Laurent Poirel
Journal:  J Med Microbiol       Date:  2013-05-02       Impact factor: 2.472

Review 9.  β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula.

Authors:  Hosam M Zowawi; Hanan H Balkhy; Timothy R Walsh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

10.  Whole genome sequence analysis of the first Australian OXA-48-producing outbreak-associated Klebsiella pneumoniae isolates: the resistome and in vivo evolution.

Authors:  Björn A Espedido; Jason A Steen; Helen Ziochos; Sean M Grimmond; Matthew A Cooper; Iain B Gosbell; Sebastiaan J van Hal; Slade O Jensen
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

View more
  51 in total

1.  Genomic Characterization of Enterobacter cloacae Isolates from China That Coproduce KPC-3 and NDM-1 Carbapenemases.

Authors:  Hong Du; Liang Chen; Kalyan D Chavda; Ruchi Pandey; Haifang Zhang; Xiaofang Xie; Yi-Wei Tang; Barry N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

2.  PME-1-producing Pseudomonas aeruginosa in Qatar.

Authors:  Hosam M Zowawi; Emad Ibrahim; Melanie W Syrmis; Alexander M Wailan; Atqah AbdulWahab; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2015-04-13       Impact factor: 5.191

3.  Prevalence and drug resistance characteristics of carbapenem-resistant Enterobacteriaceae in Hangzhou, China.

Authors:  Yan Yang; Jian Chen; Di Lin; Xujian Xu; Jun Cheng; Changgui Sun
Journal:  Front Med       Date:  2017-07-08       Impact factor: 4.592

Review 4.  Metallo-β-Lactamases: Structure, Function, Epidemiology, Treatment Options, and the Development Pipeline.

Authors:  Sara E Boyd; David M Livermore; David C Hooper; William W Hope
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

5.  OXA-48-producing Enterobacteriaceae causing bacteremia, United Arab Emirates.

Authors:  Chulsoo Ahn; Adeel A Butt; Jesabel I Rivera; Maidah Yaqoob; Sara Hag; Alaa Khalil; Marthinus Pitout; Yohei Doi
Journal:  Int J Infect Dis       Date:  2014-11-13       Impact factor: 3.623

6.  Biosynthesis of Zinc Oxide Nanoparticles from Acacia nilotica (L.) Extract to Overcome Carbapenem-Resistant Klebsiella Pneumoniae.

Authors:  Elsayim Rasha; AlOthman Monerah; Alkhulaifi Manal; Ali Rehab; Doud Mohammed; Elnagar Doaa
Journal:  Molecules       Date:  2021-03-29       Impact factor: 4.411

7.  Multihospital Occurrence of Pan-Resistant Klebsiella pneumoniae Sequence Type 147 with an ISEcp1-Directed blaOXA-181 Insertion in the mgrB Gene in the United Arab Emirates.

Authors:  Ágnes Sonnevend; Akela Ghazawi; Rayhan Hashmey; Aliasgher Haidermota; Safinaz Girgis; Mubarak Alfaresi; Mohammed Omar; David L Paterson; Hosam M Zowawi; Tibor Pál
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

Review 8.  Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply "precision medicine" to antimicrobial chemotherapy?

Authors:  Federico Perez; Nadim G El Chakhtoura; Krisztina M Papp-Wallace; Brigid M Wilson; Robert A Bonomo
Journal:  Expert Opin Pharmacother       Date:  2016-03-09       Impact factor: 3.889

9.  In Vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam against OXA-48-Carrying Enterobacteriaceae Isolated as Part of the International Network for Optimal Resistance Monitoring (INFORM) Global Surveillance Program from 2012 to 2015.

Authors:  Krystyna M Kazmierczak; Patricia A Bradford; Gregory G Stone; Boudewijn L M de Jonge; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

10.  An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase.

Authors:  M Earth Hasassri; Thomas G Boyce; Andrew P Norgan; Scott A Cunningham; Patricio R Jeraldo; Scott J Weissman; Robin Patel; Ritu Banerjee; Jason M Pogue; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.